Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study (Q37010556)

17 August 2017

1 reference

title

Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study (English)

1 reference

17 August 2017

0 references

1

1 reference

17 August 2017

Philip A Wolf

2

0 references

publication date

1 December 2007

1 reference

17 August 2017

1 reference

17 August 2017

6

1 reference

17 August 2017

1106-1114

1 reference

17 August 2017

12

1 reference

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

The lifetime risk of developing breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

A standard person-years approach to estimating lifetime cancer risk. The Section of Chronic Disease and Environmental Epidemiology Minnesota Department of Health

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

A nomogram for predicting lifetime hip fracture risk from radius bone mineral density and age

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

The lifetime prevalence of mental disorders: estimation, uses and limitations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Lifetime risk of a hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

The lifetime risk of stroke: estimates from the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Estimated risks for developing obesity in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Breast Cancer in Canadian Women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

If we live long enough, will we all be demented?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Cancer incidence: life table risk versus cumulative risk

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Clinical genetics and genetic counseling in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Rates of senile dementia, Alzheimer's type, in the Baltimore Longitudinal Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Epidemiological approaches to heart disease: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

VASCULAR DISEASE OF THE BRAIN--EPIDEMIOLOGIC ASPECTS: THE FARMINGHAM STUDY.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Annual Incidence of First Silent Stroke in the United States: A Preliminary Estimate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

The effects of specific medical conditions on the functional limitations of elders in the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Incidence and risk of dementia. The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Current status of risk factors for stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Probability of stroke: a risk profile from the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Smoking decreases the duration of life lived with and without cardiovascular disease: a life course analysis of the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Lifetime risk of developing coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

The risk of congestive heart failure: sobering lessons from the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Comparison of risk estimates for selected diseases and causes of death

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Measuring the public health burden of cancer in the United States through lifetime and age-conditional risk estimates

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Older people's understanding of cumulative risks when provided with annual stroke risk information

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Geographic variation in stroke mortality in blacks and whites in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Do trends in population levels of blood pressure and other cardiovascular risk factors explain trends in stroke event rates? Comparisons of 15 populations in 9 countries within the WHO MONICA Stroke Project. World Health Organization Monitoring of T

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

International variations in hip fracture probabilities: implications for risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Trends in ethnic disparities in stroke incidence in Auckland, New Zealand, during 1981 to 2003

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Estimating lifetime risk of developing high serum total cholesterol: adjustment for baseline prevalence and single-occasion measurements.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Lifetime Risk for Diabetes Mellitus in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Effect of BMI on lifetime risk for diabetes in the U.S

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Risk tables for parkinsonism and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Lifetime risk of symptomatic carpal tunnel syndrome in Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Lifetime Risk for Developing Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death (Chicago Heart Association Detection Project in Industry)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970291-0

7 January 2021

10.1016/S1474-4422(07)70291-0

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18031707